Copelan, Edward A. https://orcid.org/0000-0002-2784-2393
Gale, Robert P.
Article History
Received: 15 September 2025
Revised: 21 October 2025
Accepted: 11 November 2025
First Online: 25 November 2025
Competing interests
: EC acknowledges Support from the Leon Levine Foundation and the Kerry and Simone Vickar Foundation. RPG acknowledges support from the UK National Institute of Health Research (NIHR) Biomedical Research Centre; he is a consultant to Antengene Biotech LLC, a Medical Director for FFFF Enterprises Inc., a speaker for Janssen Pharma and Hengrui Pharma, and sits on the Board of Directors of the Russian Foundation for Cancer Research Support and the Scientific Advisory Board of StemRad Ltd. The authors declare no competing interests.